$222.36 0.00 (%) Allergan Inc - NYSE

Jan. 28, 2015 | 04:00 PM

Partner Headlines

  1. Salix Pharma Reportedly Exploring Sale; Stock Up

    IBD | Jan. 20, 2015 | 15:06PM EST
  2. Aegean Metals Group Inc. Announces Closing of Arrangement

    GuruFocus | Jan. 16, 2015 | 11:02AM EST
  3. Valeant CEO On Allegations Against The Company And Future M&A Deals

    Benzinga | Jan. 14, 2015 | 08:38AM EST
  4. Meet 5 Top Medical Stocks Making Waves This Week

    IBD | Jan. 14, 2015 | 08:02AM EST
  5. Top Cybersecurity Stock Qualys Gets Support

    IBD | Jan. 13, 2015 | 17:42PM EST
  6. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  7. Celgene Says Q4 Earnings Beat, Sees Currency Impact

    IBD | Jan. 12, 2015 | 13:12PM EST
  8. What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts

    Benzinga | Jan. 9, 2015 | 12:53PM EST
  9. Valeant Surges On Guidance

    IBD | Jan. 8, 2015 | 18:56PM EST
  10. Four Hot Growth Stocks To Put On Your Watch List

    IBD | Jan. 8, 2015 | 18:06PM EST
  11. Will Allergan Buy Help Actavis Extend Growth Streak?

    IBD | Jan. 6, 2015 | 18:17PM EST
  12. An Investor's Guide: Market-Leading Industries In 2014

    IBD | Jan. 2, 2015 | 14:57PM EST
  13. These 5 Big Caps Saw Sales Surge Last Quarter

    IBD | Dec. 31, 2014 | 08:02AM EST
  14. U.S. M&A Seen Staying Robust In 2015, Fueled By Oil

    IBD | Dec. 29, 2014 | 18:38PM EST
  15. Energy Sector Seen as Biggest Risk to Deal Flow in 2015

    FoxBusiness | Dec. 22, 2014 | 09:00AM EST
  16. Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside

    Benzinga | Dec. 18, 2014 | 16:15PM EST
  17. Great Stocks: Valeant Pharmaceuticals Near Buy Point

    IBD | Dec. 16, 2014 | 18:11PM EST
  18. Aegean Commences Drilling at Hot Maden Gold-Copper Project, Eastern Turkey

    GuruFocus | Dec. 15, 2014 | 11:03AM EST
  19. Benzinga's Top Downgrades

    Benzinga | Dec. 15, 2014 | 09:20AM EST
  20. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  21. Where Could ValueAct Capital's New $1.5 Billion Go?

    Benzinga | Dec. 9, 2014 | 13:38PM EST
  22. Inside The IBD 50: Challenging Time For Growth Stocks

    IBD | Dec. 5, 2014 | 18:54PM EST
  23. #PreMarket Primer: Wednesday, December 3: Investors Weigh The Possibility Of More Easing In The Eurozone

    Benzinga | Dec. 3, 2014 | 08:15AM EST
  24. Top Funds Gobble Up Tech And Medical Stocks

    IBD | Dec. 2, 2014 | 18:19PM EST
  25. U.S. Stock Mutual Funds Led Advance In November

    IBD | Dec. 2, 2014 | 18:19PM EST
  26. Valeant Rises After Allergan Snub; Zeltiq In Buy Area

    IBD | Nov. 19, 2014 | 18:14PM EST
  27. Screening Pharma Stocks Amid Turnaround

    YCharts | Nov. 19, 2014 | 09:37AM EST
  28. Nasdaq, S&P, Dow Hit Highs

    IBD | Nov. 18, 2014 | 18:50PM EST
  29. Actavis'

    IBD | Nov. 18, 2014 | 18:42PM EST
  30. Vipshop, Jack in the Box Rise In After-Hours Trading

    IBD | Nov. 18, 2014 | 17:04PM EST
  31. Dow, S&P 500 Add To Gains Following Encouraging International News

    Benzinga | Nov. 18, 2014 | 17:02PM EST
  32. Stocks Hit New Milestones; BitAuto Rebounds

    IBD | Nov. 18, 2014 | 16:17PM EST
  33. Zoetis 2015 Guidance Misses As Buyout Theories Abound

    IBD | Nov. 18, 2014 | 15:15PM EST
  34. Stock Movers: Why 4 Big Drug Stocks Are Rising Today

    IBD | Nov. 18, 2014 | 14:38PM EST
  35. Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders

    Benzinga | Nov. 18, 2014 | 14:17PM EST
  36. Stocks Hold Near Fresh Milestones; Actavis Hits New High

    IBD | Nov. 18, 2014 | 13:33PM EST
  37. Ackman Pledges Support For Actavis Bid On Allergan

    Benzinga | Nov. 18, 2014 | 13:10PM EST
  38. Is Bill Ackman Back?

    Benzinga | Nov. 18, 2014 | 10:56AM EST
  39. Benzinga's Top Downgrades

    Benzinga | Nov. 18, 2014 | 08:53AM EST
  40. Citi Raises Price Target On Actavis

    Benzinga | Nov. 18, 2014 | 08:44AM EST
  41. William Blair Downgrades Allergan To Market Perform

    Benzinga | Nov. 18, 2014 | 07:29AM EST
  42. #PreMarket Primer: Tuesday, November 18: Abe To Delay Sales Tax Increase In Japan

    Benzinga | Nov. 18, 2014 | 07:23AM EST
  43. US Stock Futures Mostly Flat Ahead Of Housing Data

    Benzinga | Nov. 18, 2014 | 07:11AM EST
  44. Here Are Some Big Caps Poised To Make Gains

    IBD | Nov. 17, 2014 | 18:45PM EST
  45. Allergan Takes A Better Offer

    IBD | Nov. 17, 2014 | 18:39PM EST
  46. Five Ethical Drugmakers Keep Leadership Positions

    IBD | Nov. 17, 2014 | 18:27PM EST
  47. Benzinga's M&A Chatter for Monday November 17, 2014

    Benzinga | Nov. 17, 2014 | 18:11PM EST
  48. Actavis' $66 Bil Offer Steals Allergan From Valeant

    IBD | Nov. 17, 2014 | 17:31PM EST
  49. U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts

    Benzinga | Nov. 17, 2014 | 16:46PM EST
  50. Stocks End Mixed As Allergan Jumps On Actavis Deal

    IBD | Nov. 17, 2014 | 16:16PM EST
Trading Center